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Abstract
Gambiense human African trypanosomiasis (gHAT, sleeping sickness) is one of several
neglected tropical diseases (NTDs) where there is evidence of asymptomatic human infec-
tion but there is uncertainty of the role it plays in transmission and maintenance. To explore
possible consequences of asymptomatic infections, particularly in the context of elimination
of transmission—a goal set to be achieved by 2030—we propose a novel dynamic transmis-
sion model to account for the asymptomatic population. This extends an established frame-
work, basing infection progression on a number of experimental and observation gHAT
studies. Asymptomatic gHAT infections include those in people with blood-dwelling trypano-
somes, but no discernible symptoms, or those with parasites only detectable in skin. Given
current protocols, asymptomatic infection with blood parasites may be diagnosed and
treated, based on observable parasitaemia, in contrast to many other diseases for which
treatment (and/or diagnosis) may be based on symptomatic infection. We construct a model
in which exposed people can either progress to either asymptomatic skin-only parasite
infection, which would not be diagnosed through active screening algorithms, or blood-para-
site infection, which is likely to be diagnosed if tested. We add extra parameters to the base-
line model including different self-cure, recovery, transmission and detection rates for skin-
only or blood infections. Performing sensitivity analysis suggests all the new parameters
introduced in the asymptomatic model can impact the infection dynamics substantially.
Among them, the proportion of exposures resulting in initial skin or blood infection appears
the most influential parameter. For some plausible parameterisations, an initial fall in infec-
tion prevalence due to interventions could subsequently stagnate even under continued
screening due to the formation of a new, lower endemic equilibrium. Excluding this scenario,
our results still highlight the possibility for asymptomatic infection to slow down progress
towards elimination of transmission. Location-specific model fitting will be needed to deter-
mine if and where this could pose a threat.
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Author summary
Gambiense African sleeping sickness is an infectious disease targeted for elimination of
transmission by 2030. Despite this there is still some uncertainty how frequently some
infected people who may not have symptoms could “self-cure” without ever having dis-
ease and whether some types of infections, such as infections only in the skin, but not the
blood, could still contribute to transmission, yet go undiagnosed. To explore how prob-
lematic these asymptomatic infections could be in terms of the elimination goal, we use a
mathematical model which quantitatively describes changes to infection and transmission
over time and includes these different types of infection. We use results of published
experimental or field studies as inputs for the model parameters governing asymptomatic
infections. We examined the impact of asymptomatic infections when control interven-
tions are put in place. Compared to a baseline model with no asymptomatics, including
asymptomatic infection using plausible biological parameters can have a profound impact
on transmission and slow progress towards elimination. In some instances it could be
possible that even after initial decline in sleeping sickness cases, progress could stagnate
without reaching the elimination goal at all, however location-specific modelling will be
needed to determine if and where this could pose a threat.
Introduction
Gambiense human African trypanosomiasis (gHAT, sleeping sickness) is one of the often fatal
neglected tropical diseases [1, 2], with the causative parasite, Trypanosoma brucei gambiense,
transmitted to humans through the a bite of tsetse (Glossina). Transmission of gHAT has
reduced significantly in the recent years—from 37,385 globally reported cases in 1998 to less
that 1000 in 2019—thanks to a range of interventions in endemic areas [3].
Tsetse are obligate blood-feeders and biological transmission of the parasite to humans is
usually considered to be through the injection trypanosomes into blood during feeding.
Trypanosomes can replicate in the blood and this is why gHAT infection is associated with
presence of parasite in blood [4]. However, various studies, in experimental animal models
and recently in humans, observed localised aggregation of trypanosomes in the skin matrix
[5–8]. Further animal experiments observe accumulation of sequestered trypanosomes in
other organs such as the spleen, liver, brain, and extravascular adipose tissue [9–11].
The existence of parasites in skin has even been reported when there is an absence of detect-
able parasites in blood. These “skin-only” infections are postulated to cause infections
which may spontaneously disappear without any treatment, or alternatively develop into a
blood infection [12, 13]. Whilst most infection to vectors may be acquired through human
blood, skin and perhaps adipose tissues are believed to play a role in transmission as well
[5–7, 11].
Even putting aside skin-only infections, there may be other types of asymptomatic human
infection that could alter transmission dynamics. The natural history of gHAT infection is rel-
atively long in duration, with early infections often having minimal symptoms. A longitudinal
study in Côte d’Ivoire has previously found that some people with confirmed infections (with
detectable blood trypanosomes) that refused treatment, subsequently tested negative for infec-
tion indicating that some may have self-cured rather progress to the more severe, late-stage
disease [14].
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The current diagnostic pathway includes people first being serologically screened using fin-
ger-prick blood taken either during mass (active) screening in at-risk village, or in passive
health facilities if the patient is considered a suspect based on gHAT-like symptoms. Positive
serological suspects needs to be confirmed by microscope observation of trypanosomes in
blood, lymph or cerebrospinal fluid (CSF) [15]. This protocol does allow for identification and
treatment of people asymptomatically infected with blood parasites. Conversely there are some
blood infections that might be missed—due to good but imperfect diagnostic algorithm sensi-
tivity—and, furthermore, skin-only infections cannot be diagnosed within the current proto-
cols. Previous studies reported some seropositive individuals remain without a confirmed
parasitological diagnosis for years [16]. Similarly, there is almost no chance to find asymptom-
atic (or mildly symptomatic) infections (of any type) in passive screening, which relies largely
on symptoms to motivate the patient to seek care and as an enter point to be screened by
health care staff [17].
Despite imperfect tools, and the challenges outlined above, the global drive to control
gHAT has resulted in huge declines in reported cases and gHAT is therefore targeted by the
World Health Organization (WHO) for elimination of transmission (EOT) by 2030 [18]. The
elimination of gHAT would be a tremendous achievement, as it would for any infectious dis-
ease, however there are still a number of hurdles to overcome in the road to elimination. Two
such hurdles are detailed in Büscher et al [19]: specifically (i) the potential of either non-
human reservoir animals to play a role in the transmission and/or maintenance of infection to
humans and (ii) the existence of asymptomatic human infections which may or may not be
detectable in routine screening for infection and could have the possibility to self-cure.
Although the role of animal transmission is far from resolved, there are a number of quantita-
tive modelling studies which have previously attempted to understand the possible impact that
animals could have on achievement of the elimination goal [20–25]. Yet only two articles [12,
26] present explicit models of asymptomatic human infection with the possibility of self-curing
infections. Whilst one [12] quantifies the likely contribution to transmission of asymptomatics
in the Forécariah focus of Guinea, and the other is used for predicting timelines until elimina-
tion of transmission in former Bandundu province of DRC, there are still several outstanding
questions about how asymptomatic human infections could impact the trajectory to elimina-
tion under different intervention strategies. Therefore the importance of asymptomatic infec-
tions for the spread of the infection remains a relevant concern. The current incidence of case
reporting across Africa have now fallen to historic lows, leading to some optimism that elimi-
nation is within sight. Despite this, asymptomatic infection as a driver of transmission could
be worrisome, particularly considering the previous resurgence of the gHAT that happened
between 1970–1990 after it dipped to low levels [27].
In this manuscript, we study the potential impact of asymptomatic infection which may
self-cure on gHAT dynamics using a mathematical model. In this novel model extension we
include the possibility that skin-only parasite infections contribute to transmission. Whilst
other anatomical reservoirs have been identified, we do not include them here. Our model is
based on a previously established compartmental model developed to study the transmission
and medical interventions [22, 25, 26, 28–31]. In the next section we present a minimal model
to explicitly account for human skin-only and blood infections in this compartmental gHAT
model. We analyse how the endemic equilibrium and basic reproduction number change in
this extended model by applying sensitivity analysis and exploring parameter space. Subse-
quently we examine the impact on transmission dynamics over time as medical interventions
are applied to analyse the theoretical ramifications of asymptomatic human infection on
achievement of the 2030 goal.
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Materials and methods
The novel model presented here to study asymptomatic infections of gHAT dynamics is based
on a baseline model presented in Rock et al. [22] and with various adaptations made, resulting
in the latest version presented in Crump et al. [30]. The baseline model takes into account dif-
ferent subpopulations of humans and tsetse, represented by compartments of different infec-
tion states. Humans can be exposed and subsequently become infectious through a bite of an
infectious tsetse. They progress through stage 1 (early stage) and stage 2 (late stage) of disease
with specific rates (ηH(Y) and γH(Y)—dependent on the year, Y—respectively). Tsetse vectors
can become exposed and subsequently infectious if they bite an infectious human. Infected
people may be detected by passive or active screening, followed by treatment and recovery.
Here, we consider a version of the baseline model where humans are partitioned into two sub-
groups of (i) low-risk and participating in the active screening, and (ii) high-risk and non-par-
ticipating in active screening (full details are presented in Crump et al [30]).
To account for asymptomatic infections, we modify this model by considering two sub-
groups within the first stage infected humans, labeled as skin parasite Is
1H and blood parasite
Ib
1H populations (Fig 1). Therefore, exposed population are assumed to develop either parasite
infection with detectable levels of parasites in the blood (with probability pbs) or skin-only par-
asite infection (with probability 1 − pbs). We assume skin-only infections are asymptomatic,
and would not be diagnosed in active screening within the current protocols due to the lack of
parasite in their blood (even if these infected people may test positive in initial screening tests
such as the card agglutination test for trypanosomes (CATT) or in rapid diagnostic tests
(RDTs) based on antibody expression). We take into account asymptomatic cases in blood
parasite group as well. As the main difference, this group will be likely diagnosed in active
screening if tested (according to the sensitivity of the algorithm used—which is usually consid-
ered to be over 90%). In the novel model, we add the possibility of self-cure for both the skin-
only and blood parasite groups through the parameters obH for blood and o
s
H for skin-only.
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1Hi   ðgHðYÞ þ mHÞI2Hi
dRHi
dt
¼ ZHðYÞIb1Hi þ gHðYÞI2Hi   ðoH þ mHÞRHi:
ð1Þ
The subscript i denotes that human subpopulations of either high-risk or low-risk. The
dynamics of these continuous ODEs are identical for both risk groups except for the probabil-
ity of being bitten by tsetse, f(i) which is r-fold higher for the high-risk group, and when we
simulate the non-continuous active screening interventions, which is assumed to take place at
the beginning of each year, during which some infected individuals may be identified and
treated. Following analysis of the model dynamics in DRC and Chad, we try to capture the
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effect of certain subpopulations (e.g. working age males) having lower participation in screen-
ing but also being most at risk from exposure to tsetse bites, and therefore assume only low
risk individuals may present in active screening which occurs randomly and according to the
coverage in each year [22, 25].
This model accounts for different compartments within each group to describe infection
dynamics (Fig 1). Susceptible humans SHi can become exposed on a bite of an infectious tsetse.
Exposed people EHi develop either the skin-only parasite Is1Hi or blood parasite stage 1 infection
Is
1Hi; the latter eventually develops stage 2 if not detected in screening. We assume skin infec-
tions can transform to blood infections with a rate indicated by θ. Recovered populations RHi
Fig 1. Schematic of the model to describe gHAT transmission with asymptomatic infections. This multi-host model of HAT takes into account
high- and low-risk groups of humans and their interactions with tsetse vectors. Each group consists of different compartments: Susceptible humans SHi
can become exposed on a bite of an infectious tsetse. Exposed people EHi progress to become the skin-only parasite Is1Hi or blood parasite stage 1
infection Ib
1Hi; the latter eventually develops stage 2 (if not detected in screening), and once treated they recover by hospitalisation RHi. Active screening
can accelerate treatment rate of infected people, but only in those with detectable blood infection and in the low-risk group—Ib
1H1 and I2H1. This is
marked on the diagram as a grey oval. Here we assume high-risk group does not participate in active screening. By biting an infectious person, tsetse
can become exposed and subsequently infectious, EV and IV. GV represents the tsetse population not exposed to Trypanosoma brucei gambiense in the
first blood-meal and are therefore less susceptible in the following meals. Rates are shown by Greek letters associated with arrows. An animal reservoir
is not considered. This figure is a modified version of the original one [22, 30].
https://doi.org/10.1371/journal.pcbi.1009367.g001
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include all people treated in screening programs. The rates of transitions between compart-
ments are described by parameters listed in Table 1.
Passive screening is considered in the equations with the rates proportional to ηH(Y) and
γH(Y) corresponding to the first and second stages of the disease. Before 1998 (pre-active
screening) it was assumed that passive detection was less effective due to lack of good diagnos-
tic test availability, and only so identified stage 2 individuals at a rate uð1997ÞgpreH , which is
smaller than the stage 2 passive detection rate in 1998, uð1998ÞgpostH . Following previous model-
ling work using gHAT data from former Bandundu province, there is a strong signal from epi-
demiological staging data that passive screening has improved during the time period from
2000–2012 [26, 30]. To capture the improvement of stage 1 to stage 2 passive detection, the
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where Y is the year and ηH(Y) is the annual stage 1 passive detection rate. Parameters dictating
the amplitude, steepness and switching year can be found in Table 1. u(Y) is calculated accord-
ingly to keep the death rate (1 − u(Y))γH(Y) fixed.
Equations for vector dynamics are very similar to the baseline model, with the only change
occurring in the ability to take a meal from the different subpopulations of infected people:
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As shown in Fig 1 and similar to the baseline model, this model considers different compart-
ments of tsetse, describing the pupal stage PV that can develop adults, which form susceptible
vectors SV. By biting an infectious person, tsetse can become exposed and subsequently infec-
tious, EV and IV. GV represents the tsetse population not exposed to Trypanosoma brucei gam-
biense in the first blood-meal with reduced susceptibility in the following meals. The actual
number the total population of adult tsetse is normalised to match the number of humans NH,
through a non-dimensionalisation process outlined in Rock et al. [22] to reduce the number of
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Table 1. Model parameters. Notation, description, and a range of all parameters used for sensitivity analysis. We split
the list by those parameters that are typically considered as fixed in previous analysis of the baseline model, those that
are featured in the baseline model but are fitted to data, and the five new parameters that are new to this asymptomatic
model variant. We also show the one with the highest likelihood for the health zone Mosango.
Notation Description Range Unit
Fixed parameters
μH Natural human mortality rate 5.48 [4.3,6.1] ×
10−5
days−1
σH Human incubation rate 0.0833 [0.03,
0.5]
days−1
φH Stage 1 to 2 progression rate 0.0019 [0.001,
0.003]
days−1
ωH Recovery rate/waning-immunity rate 0.006 [0.002,
0.01]
days−1
Sens Active screening diagnostic sensitivity 0.91 [0.85, 0.99] -
BV Tsetse birth rate� - days−1
ξV Pupal death rate 0.037 [0.02,
0.05]
days−1
K Pupal carrying capacity =111.09 [80,
200]NH
P Probability of pupating 0.75 [0.6, 0.9]
μV Tsetse mortality rate 0.03 [0.014,
0.047]
days−1
σV Tsetse incubation rate 0.034 [0.025,
0.1]
days−1
α Tsetse bite rate 0.333 [0.2, 0.5] days−1
pV Probability of tsetse infection per single infective bite 0.065 [0.05,
0.08]
-
ε Reduced non-teneral susceptibility factor 0.05 [0.02, 0.08] -
fH Proportion of blood-meals on humans 0.09[0.05, 1] -
Fitted parameters
R0 Basic reproduction number 1.015 [1.001,
1.3]
-
meff Effective tsetse density which is equal to the probability of human infection
from a single blood meal by an infectious tsetse times the tsetse to human
population density�.
- -
r Relative bites taken on high-risk humans 3.322 [1.1, 20] -
k1 Proportion of low-risk people 0.909 [0.5, 0.99] -
Spec Active screening diagnostic specificity 0.9994 [0.996,
1]
-
u(1998) Proportion of passive cases reported in 1998 0.276 [0.2, 0.8] -
g
pre










H Treatment rate from stage 1 (post-1998) 0.864 [0.1, 3] ×
10−4
days−1
ZHamp Relative improvement in passive stage 1 detection rate 0.752 [0.1, 5] -
gHamp Relative improvement in treatment/death rate from stage 2 0.287 [0.01, 1] -
dsteep Speed of improvement in passive detection 1.19 [0.5, 1.8] -




pbs Proportion of exposures resulting in initial blood infection 0.8 [0.4, 0.99] -
obH Self-cure rate of blood infections 1 [0, 10] × 10
−5 days−1
(Continued)
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free parameters by one. We assumed the skin infection is less transmissible compared to the
blood infection, implemented with the coefficient x.
A full list of model parameter descriptions is found in Table 1. Included in this list is the
bundled parameter, R0, which is the basic reproduction number of the baseline model, defined
by the next generation matrix approach [32] and describes average numbers of secondary
infections from an average infected individual (human or tsetse) in an otherwise susceptible
population. This parameter is important as it has regularly been used to aid model fitting to
data [22, 30]. A full derivation of R0 in the asymptomatic model is given in “S1 Methods”.
Estimating model parameters
This model is characterised by the parameters listed in Table 1. It is important to use the
appropriate values of the parameters, however, many of them are difficult to estimate or could
vary by location. The baseline model contains two sets of parameters, fixed and fitted ones.
Fixed parameters are estimated based on available data in the literature, however, there is still
uncertainty about their exact values. For instance, natural human mortality rate, μH, is esti-
mated based on World Bank reports on life expectancy, which changes between different
gHAT-endemic regions and also over time [33]. We therefore come up with an accepted range
for each fixed parameter shown Table 1.
Fitted parameters default values are taken from posterior distributions by fitting the model
to the health-zone-level data for different health zones of the Democratic Republic of Congo
(DRC) using an adaptive Metropolis-Hastings Markov chain Monte Carole (MCMC) algo-
rithm. In previous studies, informative priors were used for fitting parameters based on some
estimates available in the literature or values coming from fitting the model to data at the prov-
ince level [22, 30]. In the present study we use these priors to inform the possible range that
parameters might take and expand some of them to account for possible fluctuation since the
model structure has now been changed. For instance, the basic reproduction number, R0,
could potentially reach higher values even for the same observed case incidence due to the
asymptomatic infection compared to the baseline model.
Apart from the parameters of the baseline model, five extra parameters are introduced in
our minimal asymptomatic model as discussed in the previous section, indicated by an orange
colour in Table 1. Considering the nature of asymptomatic infection, it is not straightforward
to quantify the corresponding parameters ranges. Our main purpose in this research is to
study sensitivity of the model extension with respect to the asymptomatic parameters, and to
avoid overestimating it, we make some assumptions about the biology to constraint the ranges.
For instance, the blood infections are assumed to be the dominant form of infection. Our
default value for the proportion was influenced by two studies, one showing skin biopsies from
DRC revealed 6/1121 samples were skin parasite positive from people who had no gHAT diag-
nosis (either clinical signs or blood parasites), during a period when reported gHAT incidence
in the area at the time was 1.5–2% [7]. Another study in Guinea shows 40/5418 were CATT
Table 1. (Continued)
Notation Description Range Unit
osH Self-cure rate of skin-only infections 6 [1, 10] × 10
−4 days−1
θ Transition rate from skin-only infection to blood infection 2.5 [1, 5] × 10−4 days−1
x Relative infectiousness of a skin-only infection compared to a blood infection 0.5 [0, 1] -
�This parameter is not directly fitted but post-calculated after fitting R0
https://doi.org/10.1371/journal.pcbi.1009367.t001
PLOS COMPUTATIONAL BIOLOGY A model to study potential impact of asymptomatic infections on sleeping sickness dynamics
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1009367 September 13, 2021 8 / 21
positive among which 28 were confirmed via blood parasitology, while for all 26 CATT posi-
tives enrolled in the study (8 unconfirmed and 16 confirmed) trypanosomes were identified in
their skin samples via staining by a T. brucei-specific antibody [13]. It is important to note that
the relative proportions of skin-only and blood infections observed in cross-sectional survey
do not alone give the full picture as average time spend infected in each state influences these
observations. Considering uncertainties around this parameter including small sample sizes
from published studies, we use a fairly broad range for proportion of blood infection pbs to
include lower values starting from 40%. Moreover, the transmissibility of skin-only parasite
infection is probably lower compared to blood infection (a mouse study found that skin infec-
tions without detectable blood parasites were around 60% as likely to infect tsetse compared to
skin and blood infections [7]), and we therefore consider relative infectiousness of a skin infec-
tion x between 0 and 1.
The other parameters, self-cure rates from skin and blood infection populations as well as
transition rate from skin to blood infection population, can have substantial influence on the
infection dynamics. In this study we choose these parameters more cautiously based on some
estimates in literature. For self cure from blood infections we utilised data from a small sample
size study in Côte d’Ivoire—the study followed up patients refusing treatment where, out of 15
people who were originally (blood) parasite positive, nine were parasite negative after around
3.5 years [34]. In [14], out of 53 followed-up patients who had confirmed blood infections and
refused treatment in 1995/96, by 1999, nine had become parasite negative, and by 2002 three
more were parasite negative. Therefore we might assume that at least 12/53 blood infections
result in no symptoms developing. During follow up at least 31 infected people developed
symptoms or died due to HAT disease indicating that more people with blood parasites prog-
ress to disease rather than self-curing (obH < ZHðYÞ þ φH þ mH). The self-cure rate from skin-
only infections, osH , can be in part guided by a study in Guinea that followed up 5 unconfirmed
CATT positive for whom CATT and skin staining was initially positive, but 4 of these people
became negative in CATT and skin biopsy after 6 months [13]. Unfortunately without know-
ing when initial infection occurred and with a very small number of infections of this type
identified it is hard to pinpoint a robust estimate for the self-cure rate, and so here we assume
an upper limit of osH to be 10
−3. If osH was, in fact, even higher, the average time spend infected
as a skin-only infection would be less, and therefore there would be lower contribution from
these asymptomatics. The final unconfirmed CATT positive individual was still positive after 6
months, and was eventually diagnosed as a stage 1 case during a medical survey almost 2.5
years after enrollment we conclude transition rate from skin-only infection to blood infection,
θ, is likely smaller than its self-cure rate osH .
Model simulations
The model presented in the previous section can be solved to estimate the potential roles of the
asymptomatic infection on the transmission and dynamics of the sleeping sickness. In “S1
Methods”, we present analytical equations which give the endemic equilibrium of this ODE
model for gHAT. To study dynamics of gHAT over time in our model, we solve the Eqs 1 and
2 numerically with the help of 4th order Runge-Kutta methods using the time-step of 1 day,
which is sufficient to achieve high accuracy due to the slow infection dynamics. In these simu-
lations we start from our analytical computed endemic equilibrium, which has the advantage
of saving simulation time compared to numerical computation of the steady state. We assume
that active screening begins in 1998, and that this is the first year the system is perturbed from
steady state. We simulate continuation of active screening at a constant level—30% coverage
per year with the perfect specificity—which can only detect the blood parasite infection in low-
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risk population (as explained in the beginning of this section). The code used to perform
model simulations is included in “S1 Analysis Code”.
Results
Both the endemic equilibrium configuration and dynamic behaviour of the model are charac-
terised by the parameters shown in Table 1. To explore the role of the parameters, we first per-
form sensitivity analysis of the model. This will be followed by analysing the impact of the
additional parameters of the asymptomatic model on the endemic equilibrium and dynamics
of the system.
Sensitivity analysis of the full model
As introduced in Table 1, our compartmental model of gHAT dynamics is characterised by 32
parameters, within which five correspond to asymptomatic infection. As we explained in the
methods, there are estimates available for some of the parameters, however, all have some level
of uncertainty in their estimates to varying degrees. We then presented a plausible range of
each parameter based on available evidence in data, laboratory experiments, or accepted
understanding of the circumstances. In this section, we quantify the sensitivity of our model in











at the endemic equilibrium configuration before 1998, I0H=NH , and its relative change in 2020,
IHð2020Þ=I0H .
To perform the sensitivity analysis, we generate 100,000 random samples of sets of parame-
ters drawn uniformly from the intervals identified in Table 1. We then calculate the prevalence
values for each parameter set and calculate the sensitivity values with the help of MATLAB
using a ranked partial correlation method (https://uk.mathworks.com/help/sldo/ref/sdo.
analyze.html). Fig 2 shows the sensitivity of I0H=NH and IHð2020Þ=I
0
H sorted in the order of
parameters’ influence. Although the analysis is done for all parameters, the ones with negligible
sensitivity values < 0.01 are left out of the plots.
We first look at the baseline model without asymptomatic population by setting
ðpbs;obHÞ ¼ ð1; 0Þ, so that there are no skin-only infections and no self-cure. Our results show
the endemic equilibrium condition is almost invariant to many parameters and the dominat-
ing parameters are the basic reproduction number, R0, relative bites taken on high-risk
humans, r, and proportion of low-risk people, k1. As we would expect, more parameters, such
as the ones characterising passive detection rates and their change over time, contribute to the
disease dynamics, here measured by the relative change in prevalence over time IHð2020Þ=I0H .
Another interesting remark is that our real-world observables (e.g. case reporting) are, in gen-
eral, mainly sensitive to the parameter we had characterised as “fitted parameters” of the
model and rather vary little with changes to the fixed parameters.
Performing the sensitivity analysis for the asymptomatic model shows the endemic equilib-
rium is not influenced much by asymptomatic parameters, however, these parameters play
considerable roles in the system dynamics. As shown in the example of IHð2020Þ=I0H in Fig 2,
the proportion of infections progressing directly to blood infections rather than skin-only
infections, pbs, is found to be the most decisive parameter, even compared to R0.
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Fig 2. Sensitivity analysis in terms of model parameters. Sensitivity of total human prevalence, IH/NH, analysed for the whole
parameter space of the baseline model (first row) and the asymptomatic model (second row). The first column corresponds to the
endemic equilibrium configuration, I0H=NH , and second column represents the relative change in prevalence between 1998 and 2020,
IHð2020Þ=I0H . We do not show parameters with sensitivity values below 1% and sort the parameters by their absolute sensitivity value in
each plot. Fixed, fitted, and asymptomatic parameters are shown in gray, blue, and orange respectively.
https://doi.org/10.1371/journal.pcbi.1009367.g002
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Endemic equilibrium of the asymptomatic model
After performing the general sensitivity analysis for our model to all parameters, we carefully
study how endemic equilibrium is influenced by individual parameters corresponding to the
asymptomatic infection. We therefore choose a set of parameters, here the one with the highest
likelihood achieved by fitting the model to the available data in a moderate-risk setting in the
DRC—a health zone named Mosango in Kwilu province. We then systematically analyse
how each parameter of the asymptomatic model influences the prevalence at the endemic
equilibrium.
To focus on this effect, we keep all the fitted and fixed parameters the same as as the base-
line model and change the asymptomatic parameters. In our model the basic reproduction
number, R0, is considered as a fitted parameter because of a prior knowledge coming from
data-based estimates. In that representation the effective tsetse density, meff, is calculated after
fitting using the posterior estimates of R0 (more details in the SI). The prevalence is then deter-
mined at the endemic equilibrium given R0 and meff. In fact, the basic reproduction number,
the prevalence, and the effective tsetse density are conjugate and fixing one can impose the
other two. We therefore consider three different cases where one of these quantities, in addi-
tion to other parameters of the baseline model, is fixed and analyse each case separately.
In the first case, the basic reproduction number, R0, is fixed. As shown in Fig 3, endemic
prevalence increases as the proportion of skin infection, pbs, decreases. The prevalence is also
influenced by other asymptomatic transition rate parameters, osH and θ, but it is not highly
influenced by the relative infectivity of skin-only infections, x. Apart from the total prevalence
IH/NH, we also look at uγH(Y)I2H as a measure of observable incidence through passive case
detection since our model assumes only second stage infected humans can be diagnosed at the
endemic equilibrium condition. Our stage two passive case detection incidence would be
uγH(Y)I2H per unit time, and hence varies proportional to I2H for fixed reporting rate, u, and
γH(Y = 1997). In contrast to the total prevalence, the observable incidence is expected to be
smaller in the asymptomatic model compared the baseline model. This effect is enhanced by
decreasing pbs, θ, and osH , however, the observed incidence remains unchanged as a function
of x. This figure also shows how meff needs to be adjusted to keep R0 constant.
In the second case we fix observable incidence, uγH(Y)I2H, as the baseline model and mea-
sure the corresponding R0 and meff for each choice of asymptomatic parameter set (Fig 4). The
total prevalence in the asymptomatic model changes in a qualitatively similar manner to case
1, however within a broader range. R0 follows the total prevalence and meff remains very simi-
lar to the first case as well.
The third case describes the condition when the effective tsetse density, meff, is kept con-
stant as the baseline model and it displays qualitatively different results from cases 1 and 2. In
this case, as shown in Fig 5, when the relative infectiousness of skin-only infections, x, is below
a threshold, the basic reproduction number is smaller than 1 and the endemic steady state van-
ishes. This threshold is dependent on the other model parameters, as per the basic reproduc-
tion number calculation in the SI. Above the threshold, the reproduction number and
prevalence increase with x. The x threshold is given by the parameters and mainly controlled
byosH .
Infection dynamics in the asymptomatic model
Our sensitivity analysis suggested asymptomatic infection can play a significant role in the
dynamics of the infection. In this section, we study that effect more carefully by solving equa-
tions of the gHAT dynamics as described in Eqs 1 and 2 over time.
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Similar to the endemic equilibrium analysis, we start from the baseline model using the
parameters with the most likelihood of all posterior parameter sets found by fitting the model
to data for the health zone named Mosango [30] and setting the probability of progressing to
blood infection, psb, to 1 and the self-cure from blood infection, obH , to 0. We compare the
results of the baseline model with the asymptomatic model for three cases introduced in the
previous section (fixing either R0, the observable passive incidence, or meff) by looking at the
total prevalence (IH/NH) and reported cases by year for each of the different case detection
modalities (active screening of the low-risk population or passive case detection dependent on
self-presentation following symptoms). Fig 6 shows the results for a 20% probability of skin-
Fig 3. Endemic equilibrium with fixed R0. Total prevalence, IH, observable incidence, uγH(Y)I2H, and the effective tsetse density, meff, are plotted as a
function of x, the relative infectiousness of skin-only infections compared to blood infections. The proportion of blood to skin-only infections, pbs, is fixed
for each row and different values of the self-curing skin-only infection rate,osH , and the skin-only to blood infection progression rate, θ, are shown with
various colours. There is no skin-only infection, pbs = 1, for the black lines; the dashed line represents the baseline model (with no asymptomatic
components) and the solid line represents the baseline model but with the possibility of self cure from first-stage blood infection, Ib




The prevalence and incidence are given per 10,000 people.
https://doi.org/10.1371/journal.pcbi.1009367.g003
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only infection and three different choices of relative transmission probability from skin popu-
lation, x, when the progression rates from early stage blood or skin-only infection or between
them, obH ¼ 10
  5, osH ¼ 2� 10
  4, θ = 10−4, are fixed. Figures with other values of probability
of skin-only infection are included in “S1” and “S2” Figs.
In case 1 and 2, when either of the basic reproduction number R0 or the observable inci-
dence is fixed at the initial endemic equilibrium, we see the asymptomatic infection changes
the slope of prevalence decline significantly even when skin-only infected people have compar-
atively low infectiousness (x = 0.2). Both active and passive reported cases remain considerable
in the asymptomatic model for years after it reaches threshold of 1 per 10,000 in the baseline
model for these cases.
Fig 4. Endemic equilibrium with observable incidence uγH(Y)I2H fixed. Total prevalence, IH, the basic reproduction number R0, and the effective tsetse
density, meff, are plotted as a function of x, the relative infectiousness of skin-only infections compared to blood infections. The proportion of blood to skin-
only infections, pbs, is fixed for each row and different values of the self-curing skin-only infection rate,osH , and the skin-only to blood infection progression
rate, θ, are shown with various colours. There is no skin-only infection, pbs = 1, for the black lines; the dashed line represents the baseline model (with no
asymptomatic components) and the solid line represents the baseline model but with the possibility of self cure from first-stage blood infection, Ib
1H , at a rate
obH ¼ 10
  5. The prevalence and incidence are given per 10,000 people.
https://doi.org/10.1371/journal.pcbi.1009367.g004
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Case 3, with meff fixed according to the baseline model predicts very different dynamics. In
particular for larger values of skin-only infectiousness, x, the basic reproduction number is rel-
atively high (� 1.3) at the endemic equilibrium configuration, and it may reach a new, non-
zero equilibrium in the long-term with a lower transmission level compared to the initial
endemic equilibrium. However, for x = 0.2 transmission vanishes since the basic reproduction
number is smaller than 1, in the same manner that was demonstrated by our endemic equilib-
rium results in the previous section. It is noted that, we may see a small bump in passive cases
reported around the year dchange in all cases which is a consequence of enhancing the passive
detection rates ηH(Y) and γH(Y) over time.
Fig 5. Endemic equilibrium with fixed effective tsetse density, meff. Total prevalence, IH, observable incidence, uγH(Y)I2H, and the basic reproduction
number, R0, are plotted as a function of x, the relative infectiousness of skin-only infections compared to blood infections. The proportion of blood to skin-
only infections, pbs, is fixed for each row and different values of the self-curing skin-only infection rate,osH , and the skin-only to blood infection progression
rate, θ, are shown with various colours. There is no skin-only infection, pbs = 1, for the black lines; the dashed line represents the baseline model (with no
asymptomatic components) and the solid line represents the baseline model but with the possibility of self cure from first-stage blood infection, Ib
1H , at a rate
obH ¼ 10
  5. The prevalence and incidence are given per 10,000 people.
https://doi.org/10.1371/journal.pcbi.1009367.g005
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Discussion
In this manuscript we presented a mathematical framework to study the potential impact of
different types of asymptomatic infection in the transmission and dynamics of the sleeping
sickness. We presented a model that takes into account asymptomatic cases of skin-only and
blood parasite infections. Although trypanosomes can be accumulated in other organs, but in
this study we focused on skin infection since it is much better studied and it is likely that skin-
only infections (with no detectable blood parasitaemia) could still result in transmission to
tsetse [6, 7, 11]. Our model is therefore a minimal model formulation which could be extended
to incorporate more sophisticated asymptomatic scenarios that bring additional complexity.
We performed sensitivity analysis for this model to study how different parameters influ-
ence the model outputs, including in the baseline model with no skin-only infections and no
Fig 6. Influence of asymptomatic infection on infection dynamics. Total prevalence, active cases reported (without false-positive), and passive cases
reported are plotted over the years 1998 to 2040. Each row corresponds to fixing either: (case 1) the basic reproduction number, R0, (case 2) the
observable incidence of passive detections, or (case 3) the effective tsetse density, meff. Different purple shades represent different values of relative skin-
only infection infectiousness, x, when pbs = 0.8, θ = 10−4, obH ¼ 10
  5, andosH ¼ 2� 10
  4 are fixed. The baseline model is shown as a dashed black line
in each subplot (pbs = 0 andobH ¼ 0). The prevalence and incidence are given per 10,000 people.
https://doi.org/10.1371/journal.pcbi.1009367.g006
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self-cure. This analysis provides insight into the comparative importance of each parameter
and can thereby support which parameters to select for fitting to data. The parameter ranges
included here could also help choose appropriate priors for parameters selected for fitting in
subsequent analyses, as the ranges were guided by a limited but informative selection of previ-
ous studies from the laboratory and field which reported on the natural history of infection
and the relative infectivity of gHAT in skin-only and blood infections.
The sensitivity results suggest the asymptomatic parameters can play significant roles in
model dynamics; in particular the proportion of infections which are initially blood rather
than skin-only infections (pbs), the self-cure rate from skin-only infection (osH) and the relative
infectiousness of skin-only infections (x) were highlighted as having substantive impact on
infection and reporting trends over time. We therefore systematically studied how each of
these parameters influences both the endemic equilibrium and the transmission dynamics
under medical control interventions (active and passive screening). Unsurprisingly the decay
to zero can be much slower under the model with asymptomatic infection compared to our
baseline model, due to the increased infectious pressure from the skin-only human reservoir.
For some parameter set choices, it was even possible that following rapid decline, the dynam-
ical system reached a new, lower endemic equilibrium, which would be particularly worrying
in the context of targeting gHAT for elimination of transmission by 2030.
The results presented here are not intended to provide policy guidance, as they are not fitted
to case data, but provide qualitative descriptions of the impact of choosing such a model and a
quantitative ranking of the importance of the model parameters to impact infection dynamics.
Future studies will use the model presented here to fit the new asymptomatic parameters at the
same time as the previously identified list of fitted parameters, across a range of settings to
establish the impact the potential asymptomatic infections have on long-term elimination
prospects under different intervention strategies. It will require careful consideration of avail-
able evidence to provide meaningful priors for a better estimate of the new parameters.
It should be emphasised that our model is based on the current protocols of medical diag-
noses and treatment. For instance, the failure of active screening in identifying skin-only infec-
tions due to the negative parasitological tests done on blood or plasma is a decisive assumption
for the model and was chosen to be in line with current WHO recommendation [35]. New
studies offer the hope that alternative medicines—such as acoziborole, which is in phase 3 clin-
ical trials [36]—could significantly change the paradigm of gHAT active screening if it were
approved for all seropositive individuals, or even all at-risk individuals. In such as scenario,
skin-only infections, which could have played some role in capping the potential impact of
screening programmes, could then be eligible for treatment and this could rapidly curtail
infections resulting from this reservoir. This model framework would be well-suited to exam-
ine the potential impact of new treatment options.
The new framework presented is deterministic in nature and therefore, if in order to pro-
vide predictions for elimination years, a proxy threshold must be used to specific when zero
infection is expected. Our previous analysis suggested it is possible to approximate stochastic,
local elimination using a proxy threshold, however a constant value threshold cannot be used
for different choices of model parameters and careful analysis would be required for further
quantitative estimates [37]. Alternatively a stochastic version of this model could be used in a
tau-leaping or Gillespie approach to simulate end-game dynamics, as has been used for the
baseline model [38–41].
Similar to the challenge of asymptomatic human infection, there have been debates on the
impact of animal reservoirs to sustain transmission of gHAT. On-going work by our group is sep-
arately assessing evidence for animal transmission across different geographic locations. The pre-
sented asymptomatic model can be modified as well to take into account such animal reservoir.
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This study represents an important first step in development and analysis of a model which
can describe different types of asymptomatic human infection. It can be used to explore the
potential dynamics of gHAT infection under different types of screening and treatment of
cases. It is now well placed to be used in future studies to determine location-specific impact of
asymptomatic infections on long-term dynamics and the possible routes to elimination. In
particular predictions can be made under continuation of current strategy or the use of supple-
mental strategies, which have the ability to better target skin-only infection or transmission
such as acoziborole or vector control.
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S1 Fig. Influence of asymptomatic infection on infection dynamics. Total prevalence, active
cases reported (without false-positive), and passive cases reported are plotted over the years
1998 to 2040. Each row corresponds to fixing either: (case 1) the basic reproduction number,
R0, (case 2) the observable incidence of passive detections, or (case 3) the effective tsetse den-
sity, meff. Different purple shades represent different values of relative skin-only infection
infectiousness, x, when pbs = 0.9, θ = 10−4,obH ¼ 10
  5, and osH ¼ 2� 10
  4 are fixed. The base-
line model is shown as a dashed black line in each subplot (pbs = 0 and obH ¼ 0). The preva-
lence and incidence are given per 10,000 people.
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S2 Fig. Influence of asymptomatic infection on infection dynamics. Total prevalence, active
cases reported (without false-positive), and passive cases reported are plotted over the years
1998 to 2040. Each row corresponds to fixing either: (case 1) the basic reproduction number,
R0, (case 2) the observable incidence of passive detections, or (case 3) the effective tsetse den-
sity, meff. Different purple shades represent different values of relative skin-only infection
infectiousness, x, when pbs = 0.7, θ = 10−4,obH ¼ 10
  5, and osH ¼ 2� 10
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lence and incidence are given per 10,000 people.
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